Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

10.4K
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing...
10.4K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

6.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.4K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

846
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
846
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

161
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
161
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

23
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
23

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Communicating cancer project' empowering African and Caribbean communities through forum theatre: a culturally responsive approach to early head and neck cancer detection.

Perspectives in public health·2026
Same author

Observation of the ϒ(3S) Meson and Suppression of ϒ States in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Measurement of the top quark mass using a profile likelihood approach with the lepton + jets final states in proton-proton collisions at <math></math>.

The European physical journal. C, Particles and fields·2023
Same author

Observation of τ Lepton Pair Production in Ultraperipheral Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2023
Same author

Search for Exotic Higgs Boson Decays H→AA→4γ with Events Containing Two Merged Diphotons in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2023
Same author

Observation of Same-Sign WW Production from Double Parton Scattering in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2023

Related Experiment Video

Updated: Apr 25, 2026

Imaging of Estrogen Receptor-&#945; in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
07:42

Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope

Published on: November 29, 2011

12.7K

Radioiodinated estrogen derivatives

J K Mazaitis, R E Gibson, T Komai

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |February 1, 1980
    PubMed
    Summary

    Researchers explored estrogen receptor binding with novel radioligands. Challenges with nonreceptor binding and deiodination limit accurate radioreceptor assays and clinical use.

    Area of Science:

    • Endocrinology
    • Molecular Pharmacology
    • Radiochemistry

    Background:

    • Estrogen receptors (ERs) are crucial in various physiological processes.
    • Radioligands are essential tools for studying ERs.
    • Accurate quantification of ERs is vital for understanding hormone-dependent diseases.

    Purpose of the Study:

    • To synthesize and evaluate novel radiolabeled estrogens for ER studies.
    • To assess the feasibility of using these compounds in radioreceptor assays.
    • To identify strategies for improving the utility of estrogenic radioligands.

    Main Methods:

    • Synthesis of monoiodohexestrol and two iodoethynyl estradiol derivatives labeled with iodine-125.
    • Characterization of binding affinities to 8S estrogen receptor and 4S proteins.

    More Related Videos

    Ovariectomy and 17&#946;-estradiol Replacement in Rats and Mice: A Visual Demonstration
    06:51

    Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

    Published on: June 7, 2012

    58.0K
    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
    06:18

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

    Published on: August 13, 2019

    11.7K

    Related Experiment Videos

    Last Updated: Apr 25, 2026

    Imaging of Estrogen Receptor-&#945; in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
    07:42

    Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope

    Published on: November 29, 2011

    12.7K
    Ovariectomy and 17&#946;-estradiol Replacement in Rats and Mice: A Visual Demonstration
    06:51

    Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

    Published on: June 7, 2012

    58.0K
    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
    06:18

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

    Published on: August 13, 2019

    11.7K
  • Evaluation of deiodination rates in the presence of proteins.

    • Main Results:

    • Monoiodohexestrol showed limited specific binding to the 8S ER, with significant nonreceptor protein binding.
    • Attempts to reduce nonreceptor binding were not fully effective, hindering accurate receptor site determination.
    • Iodoethynyl estradiol derivatives, though stable during synthesis, rapidly deiodinated in protein environments, precluding in vivo/in vitro application.

    Conclusions:

    • Current radiolabeled estrogens face limitations due to nonreceptor binding and instability.
    • Chemical modifications are necessary to enhance the clinical utility of these compounds.
    • Further research is needed to develop stable and specific estrogenic radioligands for accurate ER quantification.